|
Volumn 10, Issue 4, 2006, Pages 479-486
|
Capecitabine: a new adjuvant option for colorectal cancer.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
CAPECITABINE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
CANCER STAGING;
CAUSE OF DEATH;
CHEMICALLY INDUCED DISORDER;
COLORECTAL TUMOR;
DIARRHEA;
DISEASE FREE SURVIVAL;
DRUG INTERACTION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LIFESTYLE;
MULTIVARIATE ANALYSIS;
NAUSEA;
NURSE ATTITUDE;
NURSING;
ONCOLOGY NURSING;
ORAL DRUG ADMINISTRATION;
PATIENT CARE;
PATIENT CARE PLANNING;
REVIEW;
RISK FACTOR;
SAFETY;
STOMATITIS;
UNITED STATES;
VOMITING;
ADMINISTRATION, ORAL;
ANTIMETABOLITES, ANTINEOPLASTIC;
CAUSE OF DEATH;
COLORECTAL NEOPLASMS;
CONTINUITY OF PATIENT CARE;
DEOXYCYTIDINE;
DIARRHEA;
DISEASE-FREE SURVIVAL;
DRUG INTERACTIONS;
HUMANS;
INFUSIONS, INTRAVENOUS;
LIFE STYLE;
MULTIVARIATE ANALYSIS;
NAUSEA;
NEOPLASM STAGING;
NURSE'S ROLE;
ONCOLOGIC NURSING;
PATIENT CARE PLANNING;
RISK FACTORS;
SAFETY MANAGEMENT;
STOMATITIS;
UNITED STATES;
VOMITING;
|
EID: 33750109585
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/06.CJON.479-486 Document Type: Review |
Times cited : (5)
|
References (42)
|